Ibrahim Abubakar
Pro-Provost at University College London
Ibrahim Abubakar, FMedSci is Pro-Provost (Health) at University College London where he is also the Dean of the Faculty of Population Health Sciences. He is a member of the Global Preparedness Monitoring Board, a UK National Institute for Health Research Senior Investigator, Chair, Lancet Nigeria Commission and former Chair of the World Health Organization’s Strategic and Technical Advisory Group on Tuberculosis and the WHO Clinical Trials Forum. Other previous recent roles include Director, UCL Institute for Global Health; Scientific Adviser to the House of Lords Science and Technology Select Committee – Science of COVID-19 Review and Scientific and Technical Adviser to the Nigerian Presidential Taskforce on COVID-19. Over the last 3 decades his career has spanned leadership roles in clinical, academic and public service work. He led the UCL Centre for Infectious Disease Epidemiology and was a senior investigator at the Medical Research Council Clinical Trials Unit. Prior to his appointment at UCL, he was head of TB at Public Health England where he led the UK government’s successful strategy to control TB and was Professor in Health Protection at the Norwich Medical School, Norwich, UK. He qualified in medicine in 1992 and initially trained in internal medicine. He undertook postgraduate public health training at the London School of Hygiene and Tropical Medicine in 1999 graduating with distinction and at the University of Cambridge in 2000. He is a Fellow of the Royal Colleges of Physicians of London and Edinburgh, the UK Faculty of Public Health and the Academy of Medical Sciences. He chairs expert and policy advisory groups for the UK National Institute for Health and Care Excellence, the World Health Organization, Wellcome Trust, the European Centre for Disease Prevention and Control and other international bodies and has provided technical support to countries in Africa, Europe and North America. He has an established research programme in infectious diseases and global health and has published over 400 research papers, policy reports, book chapters and textbooks in infectious disease epidemiology, health systems and migrant health.
